EW
NYSE
$85
Edwards Lifesciences Corp (EW)
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Sector:
Healthcare
Industry:
Medical Devices
Buy
Target: $99 (+16.47%)
Market Cap
$50B
Profit Margin
23.1%
Forward P/E
28.49
P/E Ratio
46.30
Price Chart
Valuation
Market Cap$50B
P/E46.30
Forward P/E28.49
PEG2.10
P/S8.02
P/B4.87
Profitability
Total Revenue (TTM)$6.30B
Gross Profit (TTM)$4.91B
EBITDA$1.51B
Profit Margin23.1%
Operating Margin29%
EPS$1.88
Financial Health
Debt-to-Equity5.8%
Free Cash Flow Yield2.16%
Growth & Risk
EPS 5Y CAGR+6.66%
Revenue 5Y CAGR+7.10%
FCF 5Y CAGR+8.73%
Beta (5Y)0.59
Sharpe Ratio0.41